86 related articles for article (PubMed ID: 1530341)
1. [Clinical studies on locoregional immunochemotherapy of peritonitis carcinomatosa].
Sugiyama Y; Saji S; Furuta T; Azuma S; Miya K; Umemoto T; Takao H; Kato M; Kanno A
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1724-7. PubMed ID: 1530341
[TBL] [Abstract][Full Text] [Related]
2. [Effect of intraperitoneal therapy in gastric cancer with peritoneal dissemination].
Kajiura Y; Ogoshi K; Nakamura K; Miyaji M; Kondoh Y; Makuuchi H; Tajima T; Mitomi T
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1863-6. PubMed ID: 9382552
[TBL] [Abstract][Full Text] [Related]
3. [Immunochemotherapy of carcinomatous peritonitis and pleuritis--report of 2 cases].
Takekoshi H; Yoshida K; Morinaga S
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1466-9. PubMed ID: 1326910
[TBL] [Abstract][Full Text] [Related]
4. [Intraoperative intraperitoneal administration of CDDP against gastric cancer with peritoneal dissemination].
Kano T; Kawami H; Kohdono S; Oka N; Inokuchi K
Gan To Kagaku Ryoho; 1990 Feb; 17(2):233-7. PubMed ID: 2105697
[TBL] [Abstract][Full Text] [Related]
5. [Intraoperative intraperitoneal administration of mitomycin C and OK-432 for peritoneal dissemination of gastric cancer].
Sugiyama Y; Yoshida A; Takao H; Kunieda K; Miya K; Azuma S; Tanemura H; Furuta T; Saji S
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1592-5. PubMed ID: 2117890
[TBL] [Abstract][Full Text] [Related]
6. [A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
Nakamura T; Shimada K; Okubo Y; Tanaka S; Tanabe S; Yoshida M; Doi K; Uchinami M; Horiuchi T; Tanaka K
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1423-6. PubMed ID: 15446570
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of intraperitoneal chemotherapy using CDDP combined with MMC in gastric carcinomatous peritonitis].
Kitamura M; Arai K; Iwasaki Y
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2330-3. PubMed ID: 7944472
[TBL] [Abstract][Full Text] [Related]
8. [Immunological effects of locoregional immunochemotherapy for liver metastases of gastric cancer].
Sugiyama Y; Kato M; Takao H; Kida H; Kunieda K; Umemoto T; Miya K; Azuma S; Furuta T; Saji S
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1461-4. PubMed ID: 8373205
[TBL] [Abstract][Full Text] [Related]
9. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
[TBL] [Abstract][Full Text] [Related]
10. [Intraperitoneal cavity injection of OK-432 with fresh human serum in a case of carcinomatous peritonitis--determination on the complement-derived chemotactic factor].
Kato H; Kondo Y; Tanigawa M; Kin R; Sugino S; Kondo M
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3251-5. PubMed ID: 3777961
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effect of intraperitoneal administration of CDDP and OK-432 in peritonitis carcinomatosa cases in postoperative gastric carcinoma].
Tanaka T; Itoi H; Matsui S; Nakae A; Nagashima K
Gan To Kagaku Ryoho; 1991 Apr; 18(4):661-3. PubMed ID: 2012407
[No Abstract] [Full Text] [Related]
12. [Intraperitoneal cancer chemotherapy using an implantable reservoir in patients with peritonitis carcinomatosa].
Tsuji Y; Nishimura A; Katsuki Y; Yasuda T; Araya E
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1800-3. PubMed ID: 1877821
[TBL] [Abstract][Full Text] [Related]
13. [The effect of intraperitoneal administration of OK-432 with recombinant interleukin-2 to patients with peritonitis carcinomatosa of recurrent gynecological cancer and changes in ascitic lymphocyte subsets].
Kanaoka Y; Umesaki N
Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):489-96. PubMed ID: 2056223
[TBL] [Abstract][Full Text] [Related]
14. [Changes of cytokine levels in ascitic fluid after intraperitoneal administration of OK-432 or CDDP].
Terashima M; Takagane A; Abe K; Kuboi M; Asahi H; Saito K
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2326-9. PubMed ID: 7944471
[TBL] [Abstract][Full Text] [Related]
15. [Effects of OK-432 intraportal administration on cell-mediated immune responses].
Minamimura T; Katsuyama S; Yamasaki K; Ookami H; Okamoto M; Masuyama K; Yamamoto K; Takemori S; Arai H; Sakamoto T; Tazawa K; Fujimaki M
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1867-9. PubMed ID: 9382553
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of intraperitoneal chemotherapy using CDDP/MMC or CDDP for gastric carcinomatous peritonitis].
Kitamura M; Arai K; Iwasaki Y
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1721-3. PubMed ID: 9382515
[TBL] [Abstract][Full Text] [Related]
17. [A case of curatively operated gastric cancer with peritonitis carcinomatosa treated by intraperitoneal administration of CDDP.Etoposide and EAP therapy].
Sakata Y; Okamura T; Kurimoto H; Ono K; Uenishi M
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2829-32. PubMed ID: 7993123
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of intraoperative peritoneal cytology and intraperitoneal chemotherapy using CDDP combined with MMC for gastric carcinomatous peritonitis].
Kitamura M; Arai K; Iwasaki Y
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1523-6. PubMed ID: 7574749
[TBL] [Abstract][Full Text] [Related]
19. [Changes in cytokine levels in ascitic fluid after intraperitoneal administration of OK-432].
Terashima M; Takagane A; Abe K; Kuboi M; Asahi H; Saito K
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1443-5. PubMed ID: 8373202
[TBL] [Abstract][Full Text] [Related]
20. Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.
Yamaguchi Y; Satoh Y; Miyahara E; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
Anticancer Res; 1995; 15(5B):2201-6. PubMed ID: 8572625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
